学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
NIFEDIPINE - RELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS
被引:85
作者
:
KLEINBLOESEM, CH
论文数:
0
引用数:
0
h-index:
0
机构:
STATE UNIV LEIDEN,CTR BIOPHARMACEUT SCI,DIV PHARMACOL,SYLVIUS LABS,POB 9503,2312 AV LEIDEN,NETHERLANDS
KLEINBLOESEM, CH
VANBRUMMELEN, P
论文数:
0
引用数:
0
h-index:
0
机构:
STATE UNIV LEIDEN,CTR BIOPHARMACEUT SCI,DIV PHARMACOL,SYLVIUS LABS,POB 9503,2312 AV LEIDEN,NETHERLANDS
VANBRUMMELEN, P
BREIMER, DD
论文数:
0
引用数:
0
h-index:
0
机构:
STATE UNIV LEIDEN,CTR BIOPHARMACEUT SCI,DIV PHARMACOL,SYLVIUS LABS,POB 9503,2312 AV LEIDEN,NETHERLANDS
BREIMER, DD
机构
:
[1]
STATE UNIV LEIDEN,CTR BIOPHARMACEUT SCI,DIV PHARMACOL,SYLVIUS LABS,POB 9503,2312 AV LEIDEN,NETHERLANDS
[2]
STATE UNIV LEIDEN,DEPT NEPHROL,2312 AV LEIDEN,NETHERLANDS
来源
:
CLINICAL PHARMACOKINETICS
|
1987年
/ 12卷
/ 01期
关键词
:
D O I
:
10.2165/00003088-198712010-00002
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:12 / 29
页数:18
相关论文
共 33 条
[1]
ACUTE AND LONG-TERM HYPOTENSIVE EFFECTS AND PLASMA-CONCENTRATIONS OF NIFEDIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
AOKI, K
论文数:
0
引用数:
0
h-index:
0
AOKI, K
SATO, K
论文数:
0
引用数:
0
h-index:
0
SATO, K
KAWAGUCHI, Y
论文数:
0
引用数:
0
h-index:
0
KAWAGUCHI, Y
YAMAMOTO, M
论文数:
0
引用数:
0
h-index:
0
YAMAMOTO, M
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1982,
23
(03)
: 197
-
201
[2]
BACH PR, 1983, CLIN CHEM, V29, P1344
[3]
ACUTE ANTIHYPERTENSIVE EFFECT AND PHARMACOKINETICS OF A TABLET PREPARATION OF NIFEDIPINE
BANZET, O
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
BANZET, O
COLIN, JN
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
COLIN, JN
THIBONNIER, M
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
THIBONNIER, M
SINGLAS, E
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
SINGLAS, E
ALEXANDRE, JM
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
ALEXANDRE, JM
CORVOL, P
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
CORVOL, P
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1983,
24
(02)
: 145
-
150
[4]
BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618
[5]
IMPROVED EXERCISE TOLERANCE AFTER PROPRANOLOL, DILTIAZEM OR NIFEDIPINE IN ANGINA-PECTORIS - COMPARISON AT 1, 3 AND 8 HOURS AND CORRELATION WITH PLASMA DRUG CONCENTRATION
CHAITMAN, BR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
CHAITMAN, BR
WAGNIART, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
WAGNIART, P
PASTERNAC, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
PASTERNAC, A
BREVERS, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
BREVERS, G
SCHOLL, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
SCHOLL, JM
LAM, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
LAM, J
METHE, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
METHE, M
FERGUSON, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
FERGUSON, RJ
BOURASSA, MG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
BOURASSA, MG
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1984,
53
(01)
: 1
-
9
[6]
CIGARETTE-SMOKING AND THE TREATMENT OF ANGINA WITH PROPRANOLOL, ATENOLOL, AND NIFEDIPINE
DEANFIELD, J
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
DEANFIELD, J
WRIGHT, C
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
WRIGHT, C
KRIKLER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
KRIKLER, S
RIBEIRO, P
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
RIBEIRO, P
FOX, K
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
FOX, K
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1984,
310
(15)
: 951
-
954
[7]
CLINICAL PHARMACOKINETICS OF VERAPAMIL, NIFEDIPINE AND DILTIAZEM
ECHIZEN, H
论文数:
0
引用数:
0
h-index:
0
机构:
DR MARGARETE FISCHER BOSCH INST KLIN PHARMAKOL,AUERBACHSTR 112,D-7000 STUTTGART 50,FED REP GER
ECHIZEN, H
EICHELBAUM, M
论文数:
0
引用数:
0
h-index:
0
机构:
DR MARGARETE FISCHER BOSCH INST KLIN PHARMAKOL,AUERBACHSTR 112,D-7000 STUTTGART 50,FED REP GER
EICHELBAUM, M
[J].
CLINICAL PHARMACOKINETICS,
1986,
11
(06)
: 425
-
449
[8]
GANGJI D, 1984, BR J CLIN PHARM, V17, P29
[9]
HAMANN SR, 1983, CLIN CHEM, V29, P158
[10]
EFFECT OF FOOD INGESTION ON NIFEDIPINE ABSORPTION AND HEMODYNAMIC-RESPONSE
HIRASAWA, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
HIRASAWA, K
SHEN, WF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
SHEN, WF
KELLY, DT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
KELLY, DT
ROUBIN, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
ROUBIN, G
TATEDA, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
TATEDA, K
SHIBATA, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
SHIBATA, J
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1985,
28
(01)
: 105
-
107
←
1
2
3
4
→
共 33 条
[1]
ACUTE AND LONG-TERM HYPOTENSIVE EFFECTS AND PLASMA-CONCENTRATIONS OF NIFEDIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
AOKI, K
论文数:
0
引用数:
0
h-index:
0
AOKI, K
SATO, K
论文数:
0
引用数:
0
h-index:
0
SATO, K
KAWAGUCHI, Y
论文数:
0
引用数:
0
h-index:
0
KAWAGUCHI, Y
YAMAMOTO, M
论文数:
0
引用数:
0
h-index:
0
YAMAMOTO, M
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1982,
23
(03)
: 197
-
201
[2]
BACH PR, 1983, CLIN CHEM, V29, P1344
[3]
ACUTE ANTIHYPERTENSIVE EFFECT AND PHARMACOKINETICS OF A TABLET PREPARATION OF NIFEDIPINE
BANZET, O
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
BANZET, O
COLIN, JN
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
COLIN, JN
THIBONNIER, M
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
THIBONNIER, M
SINGLAS, E
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
SINGLAS, E
ALEXANDRE, JM
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
ALEXANDRE, JM
CORVOL, P
论文数:
0
引用数:
0
h-index:
0
机构:
INSERM,U3617,RUE FER MOULIN,F-75005 PARIS,FRANCE
CORVOL, P
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1983,
24
(02)
: 145
-
150
[4]
BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618
[5]
IMPROVED EXERCISE TOLERANCE AFTER PROPRANOLOL, DILTIAZEM OR NIFEDIPINE IN ANGINA-PECTORIS - COMPARISON AT 1, 3 AND 8 HOURS AND CORRELATION WITH PLASMA DRUG CONCENTRATION
CHAITMAN, BR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
CHAITMAN, BR
WAGNIART, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
WAGNIART, P
PASTERNAC, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
PASTERNAC, A
BREVERS, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
BREVERS, G
SCHOLL, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
SCHOLL, JM
LAM, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
LAM, J
METHE, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
METHE, M
FERGUSON, RJ
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
FERGUSON, RJ
BOURASSA, MG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV MONTREAL,SCH MED,MONTREAL H3C 3J7,QUEBEC,CANADA
BOURASSA, MG
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1984,
53
(01)
: 1
-
9
[6]
CIGARETTE-SMOKING AND THE TREATMENT OF ANGINA WITH PROPRANOLOL, ATENOLOL, AND NIFEDIPINE
DEANFIELD, J
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
DEANFIELD, J
WRIGHT, C
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
WRIGHT, C
KRIKLER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
KRIKLER, S
RIBEIRO, P
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
RIBEIRO, P
FOX, K
论文数:
0
引用数:
0
h-index:
0
机构:
NATL HEART HOSP, LONDON W1M 8BA, ENGLAND
FOX, K
[J].
NEW ENGLAND JOURNAL OF MEDICINE,
1984,
310
(15)
: 951
-
954
[7]
CLINICAL PHARMACOKINETICS OF VERAPAMIL, NIFEDIPINE AND DILTIAZEM
ECHIZEN, H
论文数:
0
引用数:
0
h-index:
0
机构:
DR MARGARETE FISCHER BOSCH INST KLIN PHARMAKOL,AUERBACHSTR 112,D-7000 STUTTGART 50,FED REP GER
ECHIZEN, H
EICHELBAUM, M
论文数:
0
引用数:
0
h-index:
0
机构:
DR MARGARETE FISCHER BOSCH INST KLIN PHARMAKOL,AUERBACHSTR 112,D-7000 STUTTGART 50,FED REP GER
EICHELBAUM, M
[J].
CLINICAL PHARMACOKINETICS,
1986,
11
(06)
: 425
-
449
[8]
GANGJI D, 1984, BR J CLIN PHARM, V17, P29
[9]
HAMANN SR, 1983, CLIN CHEM, V29, P158
[10]
EFFECT OF FOOD INGESTION ON NIFEDIPINE ABSORPTION AND HEMODYNAMIC-RESPONSE
HIRASAWA, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
HIRASAWA, K
SHEN, WF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
SHEN, WF
KELLY, DT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
KELLY, DT
ROUBIN, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
ROUBIN, G
TATEDA, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
TATEDA, K
SHIBATA, J
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV SYDNEY,ROYAL PRINCE ALFRED HOSP,HALLSTROM INST CARDIOL,CAMPERDOWN,NSW 2050,AUSTRALIA
SHIBATA, J
[J].
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY,
1985,
28
(01)
: 105
-
107
←
1
2
3
4
→